Eradication Therapies for HIV Infection: Time to Begin AgainMARGOLIS, David M.AIDS research and human retroviruses. 2011, Vol 27, Num 4, pp 347-353, issn 0889-2229, 7 p.Article

Persistent HIV infection in newborns: how soon is soon enough?MARGOLIS, David M.AIDS (London). 2014, Vol 28, Num 7, pp 1069-1070, issn 0269-9370, 2 p.Article

Curing HIV: Pharmacologic Approaches to Target HIV-1 LatencyCHOUDHARY, Shailesh K; MARGOLIS, David M.Annual review of pharmacology and toxicology (Print). 2011, Vol 51, pp 397-418, issn 0362-1642, 22 p.Article

Herpes Simplex Virus Type 2 Mimicking Necrotizing FasciitisVINIKOOR, Micbael J; WONG, Yu-Tung; MARGOLIS, David M et al.Annals of internal medicine. 2011, Vol 155, Num 8, pp 567-568, issn 0003-4819, 2 p.Article

Valproic acid without intensified antiviral therapy has limited impact on persistent HIV infection of resting CD4+ T cellsARCHIN, Nancy M; ERON, Joseph J; COFFIN, John M et al.AIDS (London). 2008, Vol 22, Num 10, pp 1131-1135, issn 0269-9370, 5 p.Article

Association of HIV neutralizing antibody with lower viral load after treatment interruption in a prospective trial (A5170)MCLINDEN, Robert J; PARIS, Robert M; POLONIS, Victoria R et al.AIDS (London). 2012, Vol 26, Num 1, pp 1-9, issn 0269-9370, 9 p.Article

Regimen Simplification to Atazanavir-Ritonavir Alone as Maintenance Antiretroviral Therapy : Final 48-Week Clinical and Virologic OutcomesWILKIN, Timothy J; MCKINNON, John E; WIEGAND, Ann et al.The Journal of infectious diseases. 2009, Vol 199, Num 6, pp 866-871, issn 0022-1899, 6 p.Article

Suppression of Human Immunodeficiency Virus Type 1 (HIV-1) Viremia with Reverse Transcriptase and Integrase Inhibitors, CD4⁺ T-Cell Recovery, and Viral Rebound upon Interruption of Therapy in a New Model for HIV Treatment in the Humanized Rag2^-/- _γc ^-/- MouseCHOUDHARY, Shailesh K; REZK, Naser L; INCE, William L et al.Journal of virology. 2009, Vol 83, Num 16, pp 8254-8258, issn 0022-538X, 5 p.Article

The Challenge of Finding a Cure for HIV InfectionRICHMAN, Douglas D; MARGOLIS, David M; DELANEY, Martin et al.Science (Washington, D.C.). 2009, Vol 323, Num 5919, pp 1304-1307, issn 0036-8075, 4 p.Article

Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression : A prospective study by AIDS clinical trials group 5170SKIEST, Daniel J; ZHAOHUI SU; MARGOLIS, David M et al.The Journal of infectious diseases. 2007, Vol 195, Num 10, pp 1426-1436, issn 0022-1899, 11 p.Article

The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNAMARGOLIS, David M; KEWN, Stephen; COULL, Jason J et al.Journal of acquired immune deficiency syndromes (1999). 2002, Vol 31, Num 1, pp 45-49, issn 1525-4135, 5 p.Article

Generation of HIV Latency in Humanized BLT MiceDENTON, Paul W; OLESEN, Rikke; MARGOLIS, David M et al.Journal of virology. 2012, Vol 86, Num 1, pp 630-634, issn 0022-538X, 5 p.Article

Efficacy of NNRTI-based antiretroviral therapy initiated during acute HIV infectionGAY, Cynthia L; MAYO, Ashley J; MARGOLIS, David M et al.AIDS (London). 2011, Vol 25, Num 7, pp 941-949, issn 0269-9370, 9 p.Article

Epigenetic Silencing of HIV-1 by the Histone H3 Lysine 27 Methyltransferase Enhancer of Zeste 2FRIEDMAN, Julia; CHO, Won-Kyung; CHU, Chung K et al.Journal of virology. 2011, Vol 85, Num 17, pp 9078-9089, issn 0022-538X, 12 p.Article

CD4+ T-Cell Decline after the Interruption of Antiretroviral Therapy in ACTG A5170 Is Predicted by Differential Expression of Genes in the Ras Signaling PathwayVAHEY, Maryanne T; ZHINING WANG; ZHAOHUI SU et al.AIDS research and human retroviruses. 2008, Vol 24, Num 8, pp 1047-1066, issn 0889-2229, 20 p.Article

Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy after sustained virologic suppressionSWINDELLS, Susan; DIRIENZO, A. Gregory; COOMBS, Robert W et al.JAMA, the journal of the American Medical Association. 2006, Vol 296, Num 7, pp 806-814, issn 0098-7484, 9 p.Article

Predictors of residual viraemia in patients on long-term suppressive antiretroviral therapyLU ZHENG; BOSCH, Ronald J; CHAN, Ellen S et al.Antiviral therapy (London). 2013, Vol 18, Num 1, pp 39-43, issn 1359-6535, 5 p.Article

No Effect of Raltegravir Intensification on Viral Replication Markers in the Blood of HIV-1-Infected Patients Receiving Antiretroviral TherapyGANDHI, Rajesh T; COOMBS, Robert W; WIEGAND, Ann et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 59, Num 3, pp 229-235, issn 1525-4135, 7 p.Article

Disulfiram Reactivates Latent HIV-1 in a Bcl-2-Transduced Primary CD4⁺ T Cell Model without Inducing Global T Cell ActivationSIFEI XING; BULLEN, Cynthia K; MARGOLIS, David M et al.Journal of virology. 2011, Vol 85, Num 12, pp 6060-6064, issn 0022-538X, 5 p.Article

Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: Implications for eradication of virus. CommentarhyMARGOLIS, David M; ARCHIN, Nancie M; FAUCI, Anthony S et al.The Journal of infectious diseases. 2007, Vol 195, Num 12, issn 0022-1899, 1734-1736, 1762-1764 [6 p.]Article

c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoterGUOCHUN JIANG; ESPESETH, Amy; HAZUDA, Daria J et al.Journal of virology. 2007, Vol 81, Num 20, pp 10914-10923, issn 0022-538X, 10 p.Article

Cyclosporin a provides no sustained immunologic benefit to persons with chronic HIV-1 infection starting suppressive antiretroviral therapy : Results of a randomized, controlled trial of the AIDS clinical trials group A5138. CommentaryHUNT, Peter W; DEEKS, Steven G; SIEG, Scott F et al.The Journal of infectious diseases. 2006, Vol 194, Num 12, issn 0022-1899, 1632-1634,1677-1685 [12 p.]Article

Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovirHOSSAIN, Mohammad M; COULL, Jason J; DRUSANO, George L et al.Antiviral research. 2002, Vol 55, Num 1, pp 41-52, issn 0166-3542Article

HIV-1 Expression Within Resting CD4⁺ T Cells After Multiple Doses of VorinostatARCHIN, Nancy M; BATESON, Rosalie; RICHMAN, Douglas D et al.The Journal of infectious diseases. 2014, Vol 210, Num 5, pp 728-735, issn 0022-1899, 8 p.Article

Latent HIV-1 Infection of Resting CD4⁺ T Cells in the Humanized Rag2^-/- γ_c^-/- MouseCHOUDHARY, Shailesh K; ARCHIN, Nancie M; CHEEMA, Manzoor et al.Journal of virology. 2012, Vol 86, Num 1, pp 114-120, issn 0022-538X, 7 p.Article